FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3693111000001108: Canesten Dermatological 1% spray (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17573901000001117 Canesten Dermatological 1% spray (Bayer Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17574001000001119 Canesten Dermatological 1% spray (Bayer Plc) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Canesten Dermatological 1% spray (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Is a Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous spray true Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Has active ingredient Clotrimazole false Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Has active ingredient Clotrimazole false Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Is a Canesten (clotrimazole) true Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Has specific active ingredient Clotrimazole true Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Canesten Dermatological 1% spray (Bayer Plc) 40 ml Is pack of False Canesten Dermatological 1% spray (Bayer Plc) Inferred relationship Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc) 40 ml Has AMP True Canesten Dermatological 1% spray (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start